Related Experiment Videos
Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth
C Pass1, V E MacRae, S F Ahmed
1The Roslin Institute and Royal School of Veterinary Studies, The University of Edinburgh, Midlothian, UK. chloe.pass@roslin.ed.ac.uk
Insights
Chronic inflammation in children can stunt bone growth by disrupting growth hormone (GH) and insulin-like growth factor-1 (IGF-I) signaling. This review explores how inflammatory cytokines and SOCS proteins, particularly SOCS2, mediate this growth inhibition.
Area of Science:
- Pediatric Endocrinology
- Molecular Biology
- Inflammation Research
Background:
- Longitudinal bone growth is a complex, regulated process occurring at the growth plate.
- Chronic pediatric inflammatory diseases are known to cause growth retardation.
- This is attributed to elevated inflammatory cytokines and suppressed growth hormone (GH)/insulin-like growth factor-1 (IGF-I) signaling.
Purpose of the Study:
- To review the intricate interactions between inflammatory cytokines and the GH/IGF-I axis in regulating bone growth.
- To elucidate the precise cellular mechanisms underlying growth inhibition in chronic inflammatory conditions.
- To emphasize the potential role of suppressors of cytokine signaling (SOCS) proteins, specifically SOCS2, in mediating this process.
Main Methods:
- Literature review focusing on the interplay between inflammation, GH/IGF-I signaling, and bone growth.
- Analysis of cellular mechanisms involved in growth plate regulation.
- Examination of the function of SOCS proteins, particularly SOCS2, in inflammatory pathways.
Main Results:
- Inflammatory cytokines can interfere with GH/IGF-I signaling pathways crucial for bone elongation.
- SOCS proteins, especially SOCS2, are implicated as key mediators in suppressing cytokine signaling.
- SOCS2 may play a significant role in inhibiting GH/IGF-I action, contributing to growth retardation.
Conclusions:
- Understanding the interaction between inflammatory cytokines and the GH/IGF-I axis is vital for addressing growth issues in pediatric inflammatory diseases.
- SOCS proteins, particularly SOCS2, represent a critical link between inflammation and impaired bone growth.
- Targeting SOCS2 or related pathways may offer therapeutic strategies to improve growth outcomes in affected children.
Abstract:
Longitudinal bone growth is a tightly regulated process that relies on complex synchronized mechanisms at the growth plate. Chronic paediatric inflammatory diseases are well accepted to lead to growth retardation and this is likely due to raised inflammatory cytokine levels and reduced growth hormone (GH)/insulin-like growth factor-1 (IGF-I) signalling. The precise cellular mechanisms responsible for this inhibition are unclear and therefore in this article, we will review the potential interactions between inflammatory cytokines and the GH/IGF-I axis in the regulation of bone growth. In particular, we will emphasis the potential contribution of the suppressors of cytokine signalling (SOCS) proteins, and in particular SOCS2, in mediating this process.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
TGF - β Signaling Pathway
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Hedgehog Signaling Pathway
Nature and Nurture
Growth of Cartilage and Bone Tissue